These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28075543)

  • 21. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
    Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
    Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
    Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy.
    Wang K; Guo B; Niu Y; Li G
    BMC Surg; 2024 Jun; 24(1):196. PubMed ID: 38926690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
    Nishikawa M; Miyake H; Harada K; Fujisawa M
    Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
    Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
    Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.
    Liu W; Liu Y; Fu Q; Zhou L; Chang Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Mar; 7(12):13976-83. PubMed ID: 26910919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J
    Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.
    Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
    Bearrick EN; Packiam V; Bhindi B; Lohse CM; Cheville JC; Mason RJ; Tollefson M; Harrington S; Dong H; Parker AS; Boorjian SA; Thompson RH; Leibovich BC
    Urol Oncol; 2021 Feb; 39(2):135.e1-135.e8. PubMed ID: 33309297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population.
    Zhu Y; Zhao YR; Yang XF; Wei MT; Niu YJ; Chang JW; Wang AX; Liang X
    Int J Urol; 2019 Jun; 26(6):624-629. PubMed ID: 30861595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.
    Rini B; Goddard A; Knezevic D; Maddala T; Zhou M; Aydin H; Campbell S; Elson P; Koscielny S; Lopatin M; Svedman C; Martini JF; Williams JA; Verkarre V; Radulescu C; Neuzillet Y; Hemmerlé I; Timsit MO; Tsiatis AC; Bonham M; Lebret T; Mejean A; Escudier B
    Lancet Oncol; 2015 Jun; 16(6):676-85. PubMed ID: 25979595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Mehra R; Nallandhighal S; Cotta B; Knuth Z; Su F; Kasputis A; Zhang Y; Wang R; Cao X; Udager AM; Dhanasekaran SM; Cieslik MP; Morgan TM; Salami SS
    JCO Precis Oncol; 2024 May; 8():e2300565. PubMed ID: 38810179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
    Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
    Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
    Darwish OM; Kapur P; Youssef RF; Bagrodia A; Belsante M; Alhalabi F; Sagalowsky AI; Lotan Y; Margulis V
    Urology; 2013 Mar; 81(3):581-6. PubMed ID: 23290145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.
    Yang L; Wu Q; Xu L; Zhang W; Zhu Y; Liu H; Xu J; Gu J
    BMC Cancer; 2015 Feb; 15():67. PubMed ID: 25886010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.